The US Food and Drug Administration (FDA) has announced that it is suing four tobacco product manufacturers for producing and selling e-cigarette liquid without authorization. These companies must submit marketing applications to the FDA, such as a pre-market tobacco product application (PMTA), and obtain authorization before introducing new e-cigarette products to the US market.
So far, the FDA has authorized 23 tobacco-flavored e-cigarette products and devices. These are currently the only e-cigarette products that may be legally sold in the United States.
On February 21, the Tobacco Products Center (CTP), a division of the FDA, imposed civil penalties against four tobacco product manufacturers for manufacturing and selling products without the required marketing authorization. This marks the first time that the CTP has imposed civil penalties against tobacco product manufacturers for failing to comply with pre-market review requirements. The CTP will continue to consider civil penalties against manufacturers who do not comply with the FD&C Act and applicable regulations.
Currently, according to this law, the maximum civil penalty for tobacco products is $19,192.
The FDA has imposed civil fines on four manufacturers as follows:
BAM Group LLC is a company that needs further context to be properly reported on. Without additional information, it is unclear what the company does and what newsworthy events it may be involved in.
Great American Vapes LLC is a company that produces vaping products.
The Vapor Corner Inc. cannot be translated to journalistic English as it appears to be a company name.
13 Vapor Co. Limited Liability Company
The FDA has stated that manufacturers who violate the law will face more enforcement actions, including seizures, injunctions, and criminal prosecutions.
References:
The Food and Drug Administration (FDA) has initiated legal action against four manufacturers of e-cigarette products by filing civil money penalty complaints.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
